Results 221 to 230 of about 5,702,542 (372)

Targeting the Menin–KMT2A interaction in leukemia: Lessons learned and future directions

International Journal of Cancer, EarlyView.
Abstract Chromosomal rearrangements involving the Mixed Lineage Leukemia gene (MLL1, KMT2A) are defining a genetically distinct subset in about 10% of human acute leukemias. Translocations involving the KMT2A‐locus at chromosome 11q23 are resulting in the formation of a chimeric oncogene, where the N‐terminal part of KMT2A is fused to a variety of ...
Florian Perner, Jayant Y. Gadrey, Scott A. Armstrong, Michael W. M. Kühn   +3 more
wiley   +1 more source

Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1- nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma [PDF]

, 1979
HJ Cohen, HR Silberman, WE Larsen, Lorraine Johnson, AA Bartolucci, JR Durant   +5 more
openalex   +1 more source

Inequalities in relative cancer survival by race, immigration status, income, and education for 22 cancer sites in Canada, a cohort study

International Journal of Cancer, EarlyView.
What's New? While net cancer survival has markedly improved in Canada over the past decades, it is unclear whether all Canadians have benefited equally due to a paucity of data disaggregated by individual‐level equity stratifiers. Using data linkage of the census with the cancer registry, the authors provide nationally representative estimates of ...
Talía Malagón, Sarah Botting‐Provost, Alissa Moore, Mariam El‐Zein, Eduardo L. Franco   +4 more
wiley   +1 more source

Multiple myeloma with intramedullary masses of M-component [PDF]

, 1975
GM Bernier, VD Duca, R Brereton, RC Graham   +3 more
openalex   +3 more sources

Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma

Blood Cancer Journal, 2023
Keiji Kurata, Anna James-Bott, Mark A. Tye, Leona Yamamoto, Mehmet K. Samur, Yu-Tzu Tai, James Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C. Christianson, N. Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E. Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C. Anderson, Udo Oppermann   +28 more
doaj   +1 more source

The significance of RB1 in multiple myeloma. [PDF]

Front Immunol
Wang Y, Yang R, Liu R, Yang R, Lin Z, He A.   +5 more
europepmc   +1 more source

IgE Multiple Myeloma: A Report of the Third Case [PDF]

, 1972
Ben G. Fishkin, Natalie Orloff, Louis E. Scaduto, David T. Borucki, Hans L. Spiegelberg   +4 more
openalex   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

International Journal of Cancer, EarlyView.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner, Tobias Berg, Daniel Sasca, Sophie‐Luise Mersiowsky, Jayant Y. Gadrey, Johanna Thomas, Michael W. M. Kühn, Michael Lübbert   +7 more
wiley   +1 more source

A Case Report of IgA-κ Type Multiple Myeloma Complicated With Hyperlipidemia. [PDF]

Clin Case Rep
Li J, Zhao J, Wang S, Wu R, Duan S, Wang H.   +5 more
europepmc   +1 more source

Tumor growth patterns in multiple myeloma [PDF]

, 1977
Jim Hokanson, Barry W. Brown, James Thompson, Benjamin Drewinko, Raymond Alexanian   +4 more
openalex   +1 more source